Company news
Nuvectis Pharma, Inc. news in 2026
Nuvectis Pharma, Inc.'s news releases, calls and decks from 2026, newest first.
Nuvectis Pharma Reports Third Quarter 2026 Financial Results and Business Highlights
November 4, 2026
Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026
November 2, 2026
Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas
October 26, 2026
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
October 9, 2026
Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma
September 24, 2026
Nuvectis Pharma To Participate in Upcoming Investor Conferences
September 3, 2026
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
August 4, 2026
Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
July 22, 2026
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
July 22, 2026
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
June 29, 2026
Nuvectis Lands Major Haisco Deal for Two Potentially Best-in-Class Compounds in Multi-Billion-Dollar Markets
June 21, 2026
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
June 21, 2026
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
May 5, 2026
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting
March 30, 2026
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
February 11, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (October 2026)
Investor deck · 24 slides · October 2026